Skip to main content
Top

CNS Drugs

Issue 4/2016

Content (8 Articles)

Leading Article

Targeting Retinoid Receptors to Treat Schizophrenia: Rationale and Progress to Date

Vladimir Lerner, Peter J. A. McCaffery, Michael S. Ritsner

Review Article

A Review of Pharmacologic Treatment for Compulsive Buying Disorder

Célia Soares, Natália Fernandes, Pedro Morgado

Open Access Review Article

Unexplained Painful Physical Symptoms in Patients with Major Depressive Disorder: Prevalence, Pathophysiology and Management

Jan Jaracz, Karolina Gattner, Krystyna Jaracz, Krystyna Górna

Original Research Article

The Effect of Gabapentin Enacarbil on Quality of Life and Mood Outcomes in a Pooled Population of Adult Patients with Moderate-to-Severe Primary Restless Legs Syndrome

Alon Y. Avidan, Daniel Lee, Margaret Park, Mark J. Jaros, Gwendoline Shang, Richard Kim

Original Research Article

Post Hoc Analysis of Potential Predictors of Response to Atomoxetine for the Treatment of Adults with Attention-Deficit/Hyperactivity Disorder using an Integrated Database

Chris Bushe, Esther Sobanski, David Coghill, Lovisa Berggren, Katrien De Bruyckere, Sami Leppämäki

Adis Drug Evaluation

Brexpiprazole: A Review in Schizophrenia

Karly P. Garnock-Jones

Adis Drug Evaluation

Lisdexamfetamine: A Review in ADHD in Adults

James E. Frampton

Erratum

Erratum to: Targeting CGRP: A New Era for Migraine Treatment

Stephanie Wrobel Goldberg, Stephen David Silberstein